Prasun Mishra

Dr Mishra (Ex Genentech, Ex NCI, Ex NIH) is the founding president and CEO of the American
Association for Precision Medicine ( and chair of ACT AAPM’s Coronavirus Taskforce He
is leading research efforts focused on preventing curing chronic diseases not only treating
the sick but also providing knowledge/tools to individuals to live longer, healthier lives

He is also the founder and CEO of Agility Pharmaceuticals, a pharmaceutical company
committed to revolutionizing drug discovery development through technology, big data,
robotics, and artificial intelligence He is a serial entrepreneur who founded his first company
after graduating high school, and his second company during his Ph D Since then, he has
accumulated a wealth of experience by building, investing, and advising numerous other
companies He is an investor, co founder/ board member of a few corporations, focused on
accelerating drug discovery/ development, data analytics, robotics, mental health, and digital
health He is also the founder of AAPM Angels and Investors AAi an investment group focused
on investing in drug discovery, diagnostics, precision medicine, technology healthcare
companies He is also the founding investor and advisor to Barcelona Ventures and serves as an
advisor to a 100 M private equity fund

Widely recognized as a thought leader in the field of ‘technology and healthcare’, Dr Mishra has
keynoted, chaired, curated, and organized numerous successful international conferences He
served as a Scientist and Principal Investigator at the pharma giant Genentech, Roche Where
he participated in several drug discovery project teams Moreover, his passion for drug
development and precision medicine has led to the identification of new drug targets,
biomarkers, companion diagnostics, and several drugs/ combinations in the clinic

His research work has been recognized globally by over 40 prestigious awards and honors Due
to his unique perspective selfless service, he is a highly respected sought after mentor to
many The companies that he has advised have raised multimillion dollars Notably, he serves
as a mentor and advisor to several VC funds and startup accelerators, including IndieBio
HIMSS/Health 2 0 ’s Project Zygote, MedLabs ZGC Capital, J&J JLabs UCSF Innovation Venture,
UCSF Invent Fund, and California Life Sciences’s FAST program, to help grow California’s life
sciences innovation ecosystem